Soumya Chatterjee

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

J H Korn, Maureen D. Mayes, M Matucci Cerinic et al. · Arthritis & Rheumatism · 2004 · 726 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts

Frank C. Arnett, Mimi Cho, Soumya Chatterjee et al. · Arthritis & Rheumatism · 2001 · 290 citations

Public Health, Biostatistics, Genetics +13

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson et al. · Arthritis & Rheumatology · 2019 · 224 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Risk of malignancy in scleroderma: A population‐based cohort study

Soumya Chatterjee, George W. Dombi, Richard K. Severson et al. · Arthritis & Rheumatism · 2005 · 132 citations

Medicine, Oncology, Cancer Epidemiology +14

A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease

Arnold E. Postlethwaite, Weng Kee Wong, Philip J. Clements et al. · Arthritis & Rheumatism · 2008 · 114 citations · Full text

Medicine, Clinical Sciences, Dermatology +14